日本中文字幕第一区_麻豆国产九九九电影_欧美日韩女同性一区_最新地址中文字幕日韩专区_996久久久无码国产精品_可以直接看的毛片网址_域名停靠盘他射门下载v1.3.8_色四月婷婷网五月天_亚洲Av无码精品狠狠爱浪潮_女厕老式沟槽式厕所

xٚgӭĵ
r(nng)ˎӛYڙ(qun)W(wng)

ɿ..ʡX

(dng)ǰλã > ИI(y)Ӎ > ЈӍϢИI(y)Ӎ
14Nr(nng)ˎ@ISOͨЇ(chung)@
l(f)rg2021/3/23    l(f)ߣxr(nng)I(y)Ƽ޹˾

 

14Nr(nng)ˎ@ISOͨЇ(chung)@

20213£14NЧɷ֫@ÇH(bio)(zhn)MISOr(nng)ˎͨg(sh)ίTRr(zhn)Ӣͨ@Ҳǽ@ӢͨаֲL{(dio)(ji)anisiflupurin݄benquitrione୲ͪbipyrazonepͪcypyrafluoneh(hun)ͪdioxopyritrionefenpyrazoneͪrimisoxafentripyrasulfoneDzͪflufenoxadiazamflumetylsulforimfluoxytioconazolemetarylpicoxamidseboctylaminexspidoxamat

@14Nr(nng)ˎ୲ͪpͪh(hun)ͪͪDzͪ҇аl(f)Чɷ@҇r(nng)ˎ(chung)ˮƽ

1 Anisiflupurin

AnisiflupurinǼֲL{(dio)(ji)IUPACQ飺2--N-(3-)-9H--6-CAS̖飺1089014-47-0ʽ飺C12H10FN5OY(ji)(gu)ʽD1

 2 Benquitrione(୲ͪ)

Benquitrioneͪh(hun)ͪȫ¹Ǽܵij݄ͨ飺୲ͪIUPACQ飺3-(2,6-׻)-6-[(2-u-6-h(hun)-1-ϩ-1-)ʻ]-1-׻-2,4(1H,3H)-ͪCAS̖飺1639426-14-4ʽ飺C24H22N2O5Y(ji)(gu)ʽD2

 ୲ͪAЎW(xu)W(xu)W(xu)Ժ⸻ڈF꠰l(f)F(xin)ČuͪpøHPPDƄ݄VVЧЧN~sݼ̱sݾF(xin)^ߵijݻԣ䌦βݺҰӷЧ(yu)߶ȰȫС͸ҲȫЃ(yu)ĶW(xu)|(zh)h(hun)Ѻ

2016꣬୲ͪD(zhun)׌oɽ|_r(nng)ɷ޹˾Q_ɷݣMЮa(chn)I(y)_l(f)ʽԓa(chn)Ʒĵӛ˴ӛԇ򞼰gʾɹһᘌͬ^(q)୲ͪg(yng)üg(sh)J飬୲ͪİl(f)F(xin)ȫ򷶇(ni)״ΌF(xin)HPPDƄ݄(yng)ڸp~sQҰβݵȸsݷصļg(sh)}

20201228_ɷȫYӹ˾|_r(nng)I(y)ƌW(xu)޹˾98%୲ͪԭˎ10%୲ͪҸ҇ȡõӛƄa(chn)Ʒͨ^o~FһsݣƄˎ飺60100/

3 Bipyrazone(pͪ)

Bipyrazone鱽݄IUPACQ飺1,3-׻-4-[2-(׻)-4-(׻)]-1H--5-1,3-׻-1H--4-CAS̖飺1622908-18-2ʽ飺C20H19F3N4O5SY(ji)(gu)ʽD3

 pͪuԭ޹˾аl(f)HPPDƄ݄Ѓ(ni)(do)ão~̎ЧСһ~sݣКVVݏصס׷ȫԺão밲ȫ(f)`Ըߵc

pͪcĿǰﳣõPPOƄ݄֮goԺͶ࿹ԵIJjҰͲˡ|ţ|ҹ~sݷЧ(yu)

2018830Kԭr(nng)sݷ޹˾҇ӛ96%pͪԭˎ10%pͪɷɢ͑Ҹ22%pͪɷɢ͑Ҹ

10%pͪɷɢ͑Ҹͨ^o~FСһ~sݣƄˎ2025/22%pͪɷɢ͑Ҹ5.5%pͪ+16.5%ȷᮐͨ^o~FСһ~sƄˎ3050/

4 Cypyrafluone(h(hun)ͪ)

Cypyrafluone鱽݄ͨ飺h(hun)ͪIUPACQ飺1-[2--3-[(3-h(hun)-5-u-1-׻-1H--4-)ʻ]-6-(׻)]-2-ͪCAS̖飺1855929-45-1ʽ飺C20H19ClF3N3O3Y(ji)(gu)ʽD4

h(hun)ͪuԭ޹˾аl(f)HPPDƄ݄_ԓ݄(yng)С̱sݵȺ

h(hun)ͪЃ(ni)(do)ãСo~̎һ̱sݼ~sКVVݏص׷ȫԺõc

h(hun)ͪcĿǰСʹõALSƄACCaseƄPS ӂfƄˎڽڿԺͶ࿹sݵķ

2018830Kԭr(nng)sݷ޹˾҇ӛ95%h(hun)ͪԭˎ6%h(hun)ͪɷɢ͑Ҹ25%h(hun)¡ɷɢ͑Ҹ3%h(hun)ͪ22%¡6%h(hun)ͪɷɢ͑Ҹ25%h(hun)¡ɷɢ͑ҸƄˎքe飺150200 160250/ͨ^o~FСһ̱sݼ~sݡ

5 Dioxopyritrione

Dioxopyritrione鷼h(hun)ͪ}ͪ݄IUPACQ飺2-(3,4-)-4-[(2-u-6-h(hun)-1-ϩ-1-)ʻ]-6-׻}-3(2H)-ͪCAS̖飺2222257-79-4ʽ飺C20H20N2O6Y(ji)(gu)ʽD5

 6 Fenpyrazone(ͪ)

Fenpyrazone鱽݄ͨ飺ͪIUPACQ飺4-{2--4-(׻)-3-[(2,2,2-)׻]}-1-һ-1H--5-1,3-׻-1H--4-CAS̖飺1992017-55-6ʽ飺C22H22ClF3N4O6SY(ji)(gu)ʽD6

ͪuԭ޹˾аl(f)HPPDƄ݄Ѓ(ni)(do)ݻԸo~̎~sݼ̱sݣ׻¡sݾкܸߵĻc׻¡ALSƄoװȫõĺﰲȫ

202017գKԭr(nng)sݷ޹˾҇ӛ95%ͪԭˎ6%ͪɷɢ͑Ҹ25%ͪݬȥɷɢ͑Ҹ3%ͪ+22%ݬȥ

6%ͪɷɢ͑ҸһsƄˎ75100/25%ͪݬȥɷɢ͑ҸһsƄˎքe飺200300150200/

7 Flufenoxadiazam

Flufenoxadiazam鱽IUPACQ飺2--4-[5-(׻)-1,2,4-f-3-]CAS̖飺1839120-27-2ʽ飺C16H9F4N3O2Y(ji)(gu)ʽD7

 

8 Flumetylsulforim

FlumetylsulforimIUPACQ飺5--4--3-׻-1-[(4-׻)]-3,4--2(1H)-ͪCAS̖飺1616664-98-2ʽ飺C12H12FN3O3SY(ji)(gu)ʽD8

9 Fluoxytioconazole

FluoxytioconazoleIUPACQ飺4-({6-[(2RS)-2-(2,4-)-1,1--2-u-3-(5--1H-1,2,4--1-)]-3-ऻ})CAS̖飺2046300-61-0ʽ飺C23H15F4N5O2SY(ji)(gu)ʽD9

10 Metarylpicoxamid

MetarylpicoxamidIUPACQ飺(2S,3S)-3-(ױ)-2-N-{[4--3-()-2-ऻ]ʻ}-L-CAS̖飺2376209-11-7ʽ飺C24H30N2O6Y(ji)(gu)ʽD10

11 Rimisoxafen

Rimisoxafenf݄IUPACQ飺3--2-[3-(׻)f-5-]5--2-CAS̖飺1801862-02-1ʽ飺C14H7Cl2F2N3O2Y(ji)(gu)ʽD11

 12 Seboctylamine()

Seboctylamine麬֬嚢ͨ飺}ƷIUPACQ飺N1--N2-[2-()һ]ҶCAS̖飺57413-95-3ʽ飺C20H45N3Y(ji)(gu)ʽD12

ɽ|ʡ_l(f)ЧͶoζNͲIJƲľzLȰl(f)ƉIJļĤƲ̲|(zh)ʹøϵy(tng)l(f)׃_־͚

Ŀǰ҇ӛa(chn)Ʒ32ҪO丯P޻ήˮly~ݲԗl߲ڗls~ݲѲݲÄ⧵~

13 Spidoxamat

Spidoxamatݭh(hun)ͪxIUPACQ飺11-(4--2,6-׻)-12-u-1,4-s-9-sp[4.2.48.25]ʮ-11-ϩ-10-ͪCAS̖飺907187-07-9ʽ飺C19H22ClNO4Y(ji)(gu)ʽD13

14 Tripyrasulfone(Dzͪ)

Tripyrasulfone鱽݄ͨ飺DzͪIUPACQ飺4-{2--3-[(3,5-׻-1H--1-)׻]-4-(׻)}-1,3-׻-1H--5-1,3-׻-1H--4-CAS̖飺1911613-97-2ʽ飺C25H27ClN6O5SY(ji)(gu)ʽD14

Dzͪuԭ޹˾аl(f)HPPDƄ݄ȫȫˮo~̱̎sݵHPPDƄ݄

DzͪVVˮ̱sݺͲ~s޲ݡǧkcɯ޵Ȼ^ܸЧǧӺͶ࿹԰޲ݡ޵ȡˮȫmˮֱ

202017Kԭr(nng)sݷ޹˾Dzͪ3a(chn)Ʒ҇ȡõӛքe飺95%Dzͪԭˎ6%Dzͪɷɢ͑Ҹ28%Dzͪɷɢ͑Ҹ

6%Dzͪɷɢ͑Ҹˮ޲ݡֱˮƄˎ115150/ˮ|؅^(q)Ƅˎ200250/؅^(q)Ƅˎ150180/

28%Dzͪɷɢ͑Ҹ25%+3%Dzֱͪˮ޲Ƅˎ200250/

Դ: r(nng)ˎYӍW(wng)